Stenocare Valuation
| STENO Stock | DKK 2.04 0.14 7.37% |
Based on Macroaxis valuation methodology, the company appears to be overvalued. Stenocare AS has a current Real Value of kr1.67 per share. The regular price of the company is kr2.04. Our model measures the value of Stenocare AS from inspecting the company fundamentals such as Current Valuation of 119.1 M, price to book of 4.21 X, and Return On Equity of -0.49 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Stenocare's price fluctuation is extremely dangerous at this time. Calculation of the real value of Stenocare AS is based on 3 months time horizon. Increasing Stenocare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Stenocare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Stenocare Stock. However, Stenocare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.04 | Real 1.67 | Hype 2.04 | Naive 1.96 |
The real value of Stenocare Stock, also known as its intrinsic value, is the underlying worth of Stenocare AS Company, which is reflected in its stock price. It is based on Stenocare's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Stenocare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Stenocare AS helps investors to forecast how Stenocare stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Stenocare more accurately as focusing exclusively on Stenocare's fundamentals will not take into account other important factors: Stenocare Total Value Analysis
Stenocare AS is at this time forecasted to have takeover price of 119.1 M with market capitalization of 106.1 M, debt of 0, and cash on hands of 20.42 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Stenocare fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
119.1 M | 106.1 M | 0 | 20.42 M |
Stenocare Asset Utilization
One of the ways to look at asset utilization of Stenocare is to check how much profit was generated for every dollar of assets it reports. Stenocare AS has a negative utilization of assets of -0.28 %, losing kr0.002782 for each krone of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each krone of assets it has. In other words, asset utilization of Stenocare AS shows how discouraging it operates for each krone spent on its assets.Stenocare Ownership Allocation
The market capitalization of Stenocare is kr106.1 Million. Stenocare AS maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.Stenocare Profitability Analysis
Net Loss for the year was (12.73 M) with loss before overhead, payroll, taxes, and interest of (6.01 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Stenocare's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Stenocare and how it compares across the competition.
About Stenocare Valuation
The stock valuation mechanism determines Stenocare's current worth on a weekly basis. Our valuation model uses a comparative analysis of Stenocare. We calculate exposure to Stenocare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Stenocare's related companies.Stenocare AS cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products in the Danish and European markets. The company was founded in 2017 and is headquartered in Allerd, Denmark. STENOCARE is traded on Copenhagen Stock Exchange in Denmark.
8 Steps to conduct Stenocare's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Stenocare's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Stenocare's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Stenocare's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Stenocare's revenue streams: Identify Stenocare's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Stenocare's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Stenocare's growth potential: Evaluate Stenocare's management, business model, and growth potential.
- Determine Stenocare's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Stenocare's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Stenocare Stock analysis
When running Stenocare's price analysis, check to measure Stenocare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stenocare is operating at the current time. Most of Stenocare's value examination focuses on studying past and present price action to predict the probability of Stenocare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stenocare's price. Additionally, you may evaluate how the addition of Stenocare to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |